Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 30,2026 No.4 Detail

Comparative study of the pharmacokinetics of Abelmoschus manihot (L.) Medic. flowers in directly taken decoction pieces and traditional decoction pieces of hyperoside in normal and nephrotic syndrome rats

Published on May. 01, 2026Total Views: 48 times Total Downloads: 11 times Download Mobile

Author: NIU Kailin 1 LUO Heng 2 ZHOU Jing 2, 3 BAI Xiaolu 2 WEN Qing 2, 3 CHEN Chu 2 WU Yan 2 ZHANG Hong 1 MENG Huix-in 1 ZHANG Lei 2, 3

Affiliation: 1. College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China 2. Lanboratory Animal Center, Sichuan Academy of Chinese Medicine Sciences, Chengdu 610041, China 3. Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine, Chengdu 610041, China

Keywords: Abelmoschus manihot (L.) Medic. Hyperoside Nephrotic syndrome Directly taken decoction pieces Traditional decoction pieces HPLC-QqQ/MS Pharmacokinetics Drug metabolism Rats

DOI: 10.12173/j.issn.2097-4922.202504070

Reference: NIU Kailin, LUO Heng, ZHOU Jing, BAI Xiaolu, WEN Qing, CHEN Chu, WU Yan, ZHANG Hong, MENG Huixin, ZHANG Lei. Comparative study of the pharmacokinetics of Abelmoschus manihot (L.) Medic. flowers in directly taken decoction pieces and traditional decoction pieces of hyperoside in normal and nephrotic syndrome rats[J]. Yaoxue QianYan Zazhi, 2026, 30(4): 595-602. DOI: 10.12173/j.issn.2097-4922.202504070.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective To establish high-performance liquid chromatography-tandem quadrupole mass spectrometry (HPLC-QqQ/MS) for the determination of the content of hyperoside in rat plasma, and to compare and analyze the pharmacokinetic characteristics of hyperoside in Abelmoschus manihot (L.) Medic. flowers directly taken decoction pieces and traditional decoction pieces in normal and nephrotic syndrome (NS) rats.

Methods After the plasma was extracted with ethyl acetate, the separation was performed on an Agilent Poroshell 120 EC C18 chromatographic column (100 mm×3 mm, 2.7 µm) , and the mobile phase was methanol 0.1% formic acid aqueous solution with a gradient elution. The detection was conducted in the negative ion mode of electric spray ion source. The pharmacokinetic parameters such as peak time (Tmax), peak concentration (Cmax), area under the drug time curve (AUC), mean drug retention time (MRT), clearance rate (CL/F) and other parameters were calculated using the DAS 2.0 software.

Results  Compared with the traditional decoction pieces, oral administration of the direct decoction pieces significantly shortened Tmax and increased Cmax in normal rats, whereas Cmax was significantly decreased in NS model rats (P<0.05). Compared with normal rats, NS model rats showed significantly increased AUC₀–t and AUC₀–∞, along with decreased V/F and CL/F following oral administration of both direct and traditional decoction pieces (P<0.05). In addition, Tmax was markedly prolonged and MRT₀–t was significantly extended after administration of the direct decoction pieces in NS model rats (P<0.05). After administration of the traditional decoction pieces, Cmax was significantly increased in NS model rats (P<0.01).

Conclusion  The pharmacokinetic profiles of hyperoside differed markedly between normal and NS model rats following oral administration of both direct and traditional decoction pieces of Abelmoschus manihot. In normal rats, the direct decoction pieces exhibited faster absorption and a shorter Tmax. In contrast, in NS model rats, the direct decoction pieces resulted in a lower peak plasma concentration and reduced fluctuation, suggesting a better safety profile compared with traditional decoction pieces. Moreover, the NS model significantly increased AUC₀–t and AUC₀–∞, while decreasing CL/F and V/F, which may be associated with impaired renal clearance and altered plasma protein binding.

Full-text
Please download the PDF version to read the full text: download
References

1. Verma PR, Patil P. Nephrotic syndrome: a review[J]. Cureus, 2024, 16(2): e53923. https://pdfs.semanticscholar.org/85bd/15a9e5d3ceafc7a5a92a154796834986f4a8.pdf.

2. 耿海云, 陈朝英, 涂娟, 等. 不同方案泼尼松治疗儿童原发性肾病综合征的疗效及复发危险因素分析[J]. 中国当代儿科杂志, 2022, 24(8): 853-857. [Geng HY, Chen CY, Tu J, et al. Clinical effect of different prednisone regimens in the treatment of children withprimary nephrotic syndrome and risk factors for recurrence[J]. Chinese Journal of Contemporary Pediatrics, 2022, 24(8): 853-857.] DOI: 10.7499/j.issn.1008-8830.2203029.

3. Tecile Prince Andolino M, Jessica Reid-Adam M. Nephrotic Syndrome[J]. Pediatr Rev, 2015, 3(36): 117-126. https://scholars.mssm.edu/en/publications/nephrotic-syndrome-3/.

4. 刘春莹, 陈磊鑫, 尚乘, 等. 儿童激素依赖和频复发性肾病综合征中西医结合治疗思路探析[J]. 中国中西医结合肾病杂志, 2023, 24(4): 352-354. [Liu CY, Chen LX, Shang C, et al. Exploring integrated traditional and western medical approaches for treating hormone-dependent and frequently relapsing nephrotic syndrome in children[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2023, 24(4): 352-354.] DOI: 10.3969/j.issn.1009-587X.2023.04.021k.

5. 王玉, 曹东维, 万毅刚, 等. 基于IRS1/PI3K/Akt通路探究黄蜀葵花总黄酮改善糖尿病肾脏疾病胰岛素抵抗和足细胞转分化的作用和机制[J]. 中国中药杂志, 2023, 48(10): 2646-2656. [Wang Y, Cao DW, Wan YG, et al. Effects and mechanisms of total flavones of Abelmoschus manihot in improvinginsulin resistance and podocyte epithelial-mesenchymal transition in diabetickidney disease based on IRS1/PI3K/Akt pathway[J]. China Journal of Chinese Materia Medica, 2023, 48(10): 2646-2656.] DOI: 10.19540/j.cnki.cjcmm.20221111.703.

6. 刘锋, 周广宇. 黄蜀葵花对慢性肾小球肾炎患者尿生化指标的影响[J]. 南京中医药大学学报, 2011, 27(3): 293-294. [Liu  F, Zhou GY. Abelmoschus manihot's effect on urine biochemical parameter in patients with chronic glomerulonephritis[J]. Journal of Nanjing University of Traditional Chinese Medicine, 2011, 27(3): 293-294.] DOI: 10.14148/j.issn.1672-0482.2011.03.011.

7. 陈佳鑫, 房其军, 万毅刚, 等. 黄蜀葵花总黄酮抑制糖尿病肾脏疾病足细胞坏死性凋亡和肾脏纤维化的作用和机制 [J]. 中国中药杂志, 2023, 48(15): 4137-4146. [Chen JX, Fang  QJ, Wan YG, et al. Effects and mechanisms of total flavones of Abelmoschus manihot in inhibitingpodocyte necroptosis and renal fibrosis in diabetic kidney disease[J]. China Journal of Chinese Materia Medica, 2023, 48(15): 4137-4146.] DOI: 10.19540/j.cnki.cjcmm.20230417.701.

8. 张元丽, 王素利, 张宇, 等. 金丝桃苷调控胰岛素受体底物1/磷脂酰肌醇3-激酶/蛋白激酶B信号通路对糖尿病肾病大鼠肾组织损伤的保护作用[J]. 中国临床药理学杂志, 2023, 39(2): 241-245. [Zhang YL, Wang SL, Zhang Y, et al. Protective effect of hyperoside on renal tissue damage in rats with diabetic nephropathyby regulating the insulin receptor substrate 1/phosphatidylinositol 3-kinase/protein kinase B signaling pathway[J]. The Chinese Journal of Clinical Pharmacology, 2023, 39(2): 241-245.] DOI: 10.13699/j.cnki.1001-6821.2023.02.019.

9. 巩春智. 金丝桃苷对脂多糖所致小鼠急性肾损伤的保护作用及其机制研究[D]. 济南: 山东大学, 2019. https://cdmd.cnki.com.cn/Article/CDMD-10422-1019113653.htm.

10. 孔露娇, 王心, 刘静, 等. 金丝桃苷通过AMPK/mTOR/ULK1信号通路对肾病综合征大鼠自噬反应的影响[J]. 中国比较医学杂志, 2023, 33(11): 88-95. [Kong LJ, Wang X, Liu J, et al. Influence of hyperoside on autophagy in rats with nephrotic syndrome through AMPK/mTOR/ULK1signaling pathway[J]. Chinese Journal of Comparative Medicine, 2023, 33(11): 88-95.] DOI: 10.3969/j.issn.1671-7856.2023.11.012.

11. 杨艳君, 邹俊波, 张小飞, 等. 超微粉碎技术在中药领域的研究进展[J]. 中草药, 2019, 50(23): 5887-5891. [Yang  YJ, Zou JB, Zhang XF, et al. Research progress on superfine grinding technique in field of Chinese materiamedica[J]. Chinese Traditional and Herbal Drugs, 2019, 50(23): 5887-5891.] DOI: 10.7501/j.issn.0253-2670.2019.23.033.

12. 马晓雯, 范胜楠, 许在平, 等. 当归芍药散对肾病综合征大鼠水肿的改善作用及机制[J]. 中国药理学通报, 2024, 40(6): 1172-1178. [Ma XW, Fan SN, Xu ZF, et al. Study on improvement effect of Danggui Shaoyao San on edema in rats with nephrotic syndrome and its mechanism[J]. Chinese Pharmacological Bulletin, 2024, 40(6): 1172-1178.] DOI: 10.12360/CPB20231009.

13. 魏世超, 徐丽君, 邹欣, 等. 比较研究黄连粉末及煎煮液中小檗碱、药根碱在2型糖尿病大鼠药动学特征[J]. 中国医院药学杂志, 2015, 35(8): 698-702. [Wei SC, Xu LJ, Zou X, et al. Pharmacokinetics of berberine and jateorrhizine from Rhizoma coptidis powder and decoction in diabetic rats[J]. Chinese Journal of Hospital Pharmacy, 2015, 35(8): 698-702.] DOI: 10.13286/j.cnki.chinhosppharmacyj.2015.08.08.

14. 中国药典2025年版. 四部[S]. 2025: 363-387.

15. 赵沛东, 翟文生. 肾病综合征国内外指南或共识治疗方案分析 [J]. 中华中医药学刊, 2025, 43(1): 108-116. [Zhao PD, Zhai  WS. Analysis of domestic and international guidelines or consensus treatment plans for nephrotic syndrome[J]. Chinese Archives of Traditional Chinese Medicine, 2025, 43(1): 108-116.] DOI: 10.13193/j.issn.1673-7717.2025.01.020.

16. 白鑫宇, 杨晓峰, 赵叶利, 等. 金丝桃苷对内毒素(LPS)诱导的小鼠急性肾损伤的保护作用[J]. 沈阳药科大学学报, 2014, 31(10): 799-803. [Bai XY, Yang XF, Zhao YL, et al. Protective effects of hyperoside on endotoxin (LPS) -induced acute kidney injury in mice[J]. Journal of Shenyang Pharmaceutical University, 2014, 31(10): 799-803.] DOI: 10.14066/j.cnki.cn21-1349/r.2014.10.009.

17. 刘燕, 张清华, 郭小藤, 等. HPLC法测定黄蜀葵花中7种黄酮类成分的含量[J]. 中国药师, 2021, 24(7): 373-376. [Liu  Y, Zhang  QH, Guo XT, et al. Determination of seven flavonoids in flowers of Abelmoschus manihot by HPLC[J]. China Pharmacist, 2021, 24(7): 373-376.] DOI: 10.19962/j.cnki.issn1008-049X.2021.07.034.

Popular papers
Last 6 months